Demographics (2)
- SEX - Sex (phv00570690.v1.p1)
- SEX - Biological sex (phv00570684.v1.p1)
Disease Events (3)
- AFFECTION_STATUS - Case control status of the subject for anthracycline-induced cardiomyopathy (phv00570688.v1.p1)
- AGE_AT_CANCER_DIAGNOSIS - Age at primary cancer diagnosis (phv00570691.v1.p1)
- CANCER_TYPE - Primary cancer diagnosis (phv00571489.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00570689.v1.p1)
Other (10)
- ANALYTE_TYPE - Analyte type (phv00570694.v1.p1)
- ANTHRACYCLINE_DOSE - Cumulative anthracycline exposure (phv00571490.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00570693.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00570683.v1.p1)
- IS_TUMOR - Tumor status (phv00570695.v1.p1)
- SAMPLE_ID - Sample ID (phv00570692.v1.p1)
- SAMPLE_ID - Subject ID (phv00570686.v1.p1)
- SUBJECT_ID - Subject ID (phv00570687.v1.p1)
- SUBJECT_ID - Subject ID (phv00570682.v1.p1)
- SUBJECT_ID - Subject ID (phv00570685.v1.p1)